Moderna Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 2.7B 6.8B 18.9B 17.7B
Cost of revenue 1.2B 4.7B 5.4B 2.6B
Gross profit 1.5B 2.1B 13.5B 15.1B
Operating expense
Research & development 3.9B 4.8B 3.3B 2.0B
Selling general and admin 1.0B 1.5B 1.1B 567M
Other operating expenses -31.5M -94M -388M -735M
Operating income -3.4B -4.2B 9.4B 13.3B
Non operating interest income
Income 362.2M 421M 200M 18M
Expense 20.5M 38M 29M 18M
Other income expense -53.7M -86M -16M -29M
Pretax income -3.1B -3.9B 9.6B 13.3B
Tax provision -39.2M 772M 1.2B 1.1B
Net income -3.0B -4.7B 8.4B 12.2B
Basic EPS -9.3 -12.3 21.3 30.3
Diluted EPS -9.3 -12.3 20.1 28.3
Basic average shares 327.3M 399.6M 410.0M 419.4M
Diluted average shares 327.3M 399.6M 410.0M 419.4M
EBITDA -2.8B -3.2B 10.0B 13.5B
Net income from continuing op. -3.0B -4.7B 8.4B 12.2B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 8 hours 10 minutes

23:49
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).